Alexandria Real Estate Equities
ARE
#2103
Rank
โ‚น881.67 B
Marketcap
โ‚น5,088
Share price
0.31%
Change (1 day)
-37.15%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚น89.1 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.94 Billion. a decrease over its 2024 earnings that were of โ‚น63.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น89.83 Billion-242.13%
2024 โ‚น63.19 B96.11%
2023 โ‚น32.22 B-53.56%
2022 โ‚น69.39 B-3.96%
2021 โ‚น72.26 B-20.26%
2020 โ‚น90.61 B72.88%
2019 โ‚น52.41 B3.11%
2018 โ‚น50.83 B73.54%
2017 โ‚น29.29 B464.88%
2016 โ‚น5.18 B-77.32%
2015 โ‚น22.86 B36.31%
2014 โ‚น16.77 B-10.81%
2013 โ‚น18.80 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.075 T-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.041 T-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น747.96 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น896.93 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น90.27 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น728.81 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.82 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA